Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Company

CourtDistrict Court, S.D. California
DecidedMarch 1, 2021
Docket3:19-cv-01667
StatusUnknown

This text of Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Company (Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Company) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Company, (S.D. Cal. 2021).

Opinion

8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 SENTYNL THERAPEUTICS, INC., CASE NO. 19cv1667-LAB-AHG 11 Plaintiff, ORDER: 12 v. 1) DENYING WITHOUT 13 PREJUDICE USSI’s U.S. SPECIALTY INSURANCE CO., APPLICATION FOR LEAVE TO 14 FILE UNDER SEAL [Dkt. 52]; 15 Defendants. 2) DENYING WITHOUT PREJUDICE USSI’s

16 APPLICATION FOR LEAVE TO FILE UNDER SEAL [Dkt. 65]; 17 3) GRANTING IN PART AND 18 DENYING WITHOUT PREJUDICE IN PART 19 SENTYNL’S APPLICATION FOR LEAVE TO FILE UNDER SEAL 20 [Dkt. 74] 4) DENYING WITHOUT 21 PREJUDICE USSI’S 22 APPLICATION FOR LEAVE TO FILE UNDER SEAL [Dkt. 77] 23 5) DENYING WITHOUT PREJUDICE SENTYNL’S 24 APPLICATION FOR LEAVE TO 25 FILE UNDER SEAL [Dkt. 81]

26 27 Plaintiff Sentynl Therapeutics (“Sentynl”) and Defendant U.S. Specialty Insurance Company (“USSI”) have filed separate Consent Ex Parte 1 Applications seeking leave to file various documents under seal. (Dkt. 2 Nos. 52, 65, 74, 77, 81.) While the parties provide compelling reasons to 3 protect the identities of non-litigants, they fail to justify shielding the 4 remaining information from public view. The Motions are DENIED WITHOUT 5 PREJUDICE except Dkt. 74, which is DENIED WITHOUT PREJUDICE IN 6 PART AND GRANTED IN PART as to Hercz Exs. B and C to Sentynl’s 7 Cross-Motion for Summary Judgment, the public versions of which redact 8 only non-party personal identifying information. 9 STANDARD OF REVIEW 10 Each of the motions to seal was filed in connection with a dispositive 11 motion—either a motion for judgment on the pleadings or a motion for 12 summary judgment. Accordingly, they are subject to a stricter standard than 13 that applied to nondispositive motions. In re Midland Nat. Life Ins. Co. 14 Annuity Sales Practices Litig., 686 F.3d 1115, 1118-19 (9th Cir. 2012). The 15 standard here requires the movant to provide “compelling reasons” for 16 sealing the record in order to overcome the “strong presumption in favor of 17 access to court records.” Id. at 1119 (quoting Foltz v. State Farm Mut. Auto. 18 Ins. Co., 331 F.3d 1122, 1129 (9th Cir. 2003)). The Court can only find 19 compelling reasons to seal where those reasons are supported with specific 20 facts. Kamakana v. City & Cty. of Honolulu, 447 F.3d 1172, 1178 (9th Cir. 21 2006) (internal marks and citation omitted). 22 DISCUSSION 23 I. Exhibits to USSI’s Opposition to Sentnyl’s Motion for Judgment 24 on the Pleadings (Dkt. 52) 25 USSI first asks to seal exhibits to its opposition to Senynl’s motion for 26 judgment on the pleadings. It argues that the exhibits are confidential and 27 sensitive because they contain discussions between Sentynl and a third- party insurance broker “contain[ing] confidential and sensitive information to 1 Sentynl’s insurance policies and the non-public [DOJ] investigation for which 2 Sentynl is seeking coverage.” (Dkt. 52 at 3.) 3 This is the extent of USSI’s argument, and it doesn’t include specific 4 facts establishing a compelling reason that the documents should be sealed. 5 The documents may be related to a non-public investigation, but they discuss 6 a wholly public part of that investigation: subpoenas filed on the public 7 docket, redacting only information not discussed in the exhibits in question. 8 (See, e.g., Dkt. 51-1 at 10-31.)1 The Motion is DENIED WITHOUT 9 PREJUDICE. (Dkt. 52.) 10 II. Memorandum and Exhibits in Support of USSI’s Motion for 11 Summary Judgment (Dkt. 65) 12 USSI next asks for leave to file under seal its unredacted memorandum 13 in support of its motion for summary judgment and Pettey Exs. B and D and 14 Bailey Exs. A, B, D, E, G, H, I, J, K, L, M, N, O, and P in support of that 15 motion. 16 A. Documents the Parties Designated as Confidential 17 Those exhibits, it argues, were either designated as “CONFIDENTIAL” 18 pursuant to a Protective Order or “contain or reflect confidential information 19 Sentynl provided pursuant to a pre-suit confidentiality agreement.” (Dkt. 65 20 at 2.) In either case, the confidentiality designation comes from the parties— 21 it doesn’t signify a court’s determination that there are compelling reasons to 22 shield the documents from public view while nevertheless considering them 23 in connection with a dispositive motion. The Court can’t delegate its role as 24 guardian of the public’s interest in access by deferring to the parties’ 25 determination that documents are confidential. See Foltz, 331 F.3d at 1136 26

27 1 In briefing on other motions addressed by this Order, the parties argue that such conversations could prejudice Sentynl’s defense or reveal confidential 1 (“[T]he presumption of access is not rebutted where, as here, documents 2 subject to a protective order are filed under seal as attachments to a 3 dispositive motion”). 4 Even if a party properly designated a document as “CONFIDENTIAL” 5 under the Protective Order, that designation indicates only a “good faith 6 belief [that] the unrestricted disclosure of such information could be 7 potentially prejudicial to the business or operations of such party or could 8 reveal otherwise confidential, proprietary, or sensitive non-public 9 information.” (Dkt. 29.) This rough approximation of Rule 26(c)(1)(G) might 10 amount to good cause. Foltz, 331 F.3d at 1138. But even had the Court found 11 that the documents fall within that Rule, mere good cause isn’t enough to 12 satisfy the stricter “compelling reasons” standard applicable here. See 13 Kamakana, 447 F.3d at 1180. 14 B. Documents Discussing the Subpoena and Insurance Coverage 15 Issues 16 Bailey Exs. B, D, and E, USSI contends, “are either e-mails between 17 Sentynl and Marsh or internal Marsh e-mails . . . [that include] their initial 18 interpretations of the subpoena and identify insurance coverage issues 19 relating to same.” (Dkt. 65 at 3.) As discussed supra, Section I, this line of 20 argument can’t stand as a compelling reason to seal without supporting facts. 21 And as before, USSI doesn’t provide any. 22 In this instance, though, Sentynl’s counsel adds that disclosure of 23 USSI’s filings might prejudice Sentynl’s defense of the investigation, risk 24 disclosing confidential government information, “negatively impact [its] 25 commercial standing,” and “risk[] unfairly, improperly, and incorrectly 26 suggesting that Sentynl . . . committed wrongdoing.” (Dkt. 65 at 4.) The latter 27 two concerns amount to “a litigant’s embarrassment, incrimination, or 1 support of a dispositive motion without more. Kamakana, 447 F.3d at 1179. 2 The parties provide nothing more of substance. Prejudice to defense of an 3 ongoing investigation and disclosure of potentially confidential government 4 information might constitute compelling reasons, but even if they are, they 5 must still be supported with specific facts. The bare assertion that some of 6 the information among hundreds of pages is “likely to materially prejudice 7 Sentynl’s ongoing defense of the investigation [or] risk[] disclosure of 8 confidential government information regarding the investigation” isn’t specific 9 enough to support a finding of compelling reasons to permit filing all or any 10 of them under seal. 11 Moreover, the record currently before the Court gives no reason to 12 believe that these documents, subject to the Civil Rules’ disclosure 13 requirements, aren’t also subject to DOJ’s subpoena power. Indeed, the DOJ 14 appears to have sought documents like these, and Sentynl may have already 15 produced them. (See Dkt. 64-4 at 14 (subpoena purporting to require 16 production of “[a]ll Documents related to any . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Sentynl Therapeutics, Inc. v. U.S. Specialty Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/sentynl-therapeutics-inc-v-us-specialty-insurance-company-casd-2021.